Phibro Animal Health (NASDAQ:PAHC) Price Target Raised to $15.00 at Bank of America

Phibro Animal Health (NASDAQ:PAHC) had its target price raised by Bank of America from $13.00 to $15.00 in a research note released on Friday morning, Benzinga reports. They currently have an underperform rating on the stock.

Separately, Barclays boosted their price target on Phibro Animal Health from $10.00 to $13.00 and gave the company an underweight rating in a research note on Friday, May 10th. Three equities research analysts have rated the stock with a sell rating, one has given a hold rating and one has given a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of Hold and an average target price of $13.25.

Phibro Animal Health Stock Performance

NASDAQ PAHC opened at $21.00 on Friday. Phibro Animal Health has a twelve month low of $9.40 and a twelve month high of $22.31. The company has a quick ratio of 1.67, a current ratio of 3.16 and a debt-to-equity ratio of 1.69. The stock has a market cap of $850.56 million, a P/E ratio of 65.63, a PEG ratio of 4.71 and a beta of 0.57. The company’s 50-day simple moving average is $18.25 and its 200 day simple moving average is $16.00.

Phibro Animal Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 25th. Investors of record on Wednesday, September 4th will be issued a dividend of $0.12 per share. The ex-dividend date of this dividend is Wednesday, September 4th. This represents a $0.48 dividend on an annualized basis and a yield of 2.29%. Phibro Animal Health’s dividend payout ratio is 150.00%.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in PAHC. Dana Investment Advisors Inc. lifted its holdings in Phibro Animal Health by 17.2% during the 2nd quarter. Dana Investment Advisors Inc. now owns 513,926 shares of the company’s stock worth $8,619,000 after buying an additional 75,546 shares in the last quarter. Truist Financial Corp acquired a new stake in Phibro Animal Health in the second quarter worth about $308,000. Brandes Investment Partners LP raised its holdings in Phibro Animal Health by 1.2% during the 2nd quarter. Brandes Investment Partners LP now owns 2,405,629 shares of the company’s stock worth $40,521,000 after purchasing an additional 29,071 shares during the last quarter. Algert Global LLC acquired a new position in Phibro Animal Health during the 2nd quarter valued at about $193,000. Finally, Deerfield Management Company L.P. Series C boosted its stake in shares of Phibro Animal Health by 102.4% in the 2nd quarter. Deerfield Management Company L.P. Series C now owns 25,164 shares of the company’s stock valued at $422,000 after purchasing an additional 12,731 shares during the last quarter. Institutional investors and hedge funds own 99.34% of the company’s stock.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.